Cargando…

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS

Human immunodeficiency virus type 1 (HIV-1) integrase inhibitors belong to a novel class of antiretroviral drugs with high potency and better tolerability. Elvitegravir (EVG) is the second integrase inhibitor approved by the US Food and Drug Administration when administered in combination with a nov...

Descripción completa

Detalles Bibliográficos
Autor principal:	Pandey, Krishan K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4037326/ https://www.ncbi.nlm.nih.gov/pubmed/24876793 http://dx.doi.org/10.2147/HIV.S39178

Ejemplares similares

Efficacy, safety, and patient acceptability of elvitegravir/cobicistat/emtricitabine/tenofovir in the treatment of HIV/AIDS
por: Prinapori, Roberta, et al.
Publicado: (2015)

Antimicrobial therapy for the treatment of opportunistic infections in HIV/AIDS patients: a critical appraisal
por: Seddon, Jo, et al.
Publicado: (2011)

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
por: Serrao, Erik, et al.
Publicado: (2009)

HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination
por: Nishana, Mayilaadumveettil, et al.
Publicado: (2017)

Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors
por: Serrao, Erik, et al.
Publicado: (2009)

An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia
por: Gong, Yuqing, et al.
Publicado: (2020)

Effect of Ethanol on the Metabolic Characteristics of HIV-1 Integrase Inhibitor Elvitegravir and Elvitegravir/Cobicistat with CYP3A: An Analysis Using a Newly Developed LC-MS/MS Method
por: Midde, Narasimha M., et al.
Publicado: (2016)

Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages
por: Gong, Yuqing, et al.
Publicado: (2017)

Review of the safety, efficacy, and pharmacokinetics of elvitegravir with an emphasis on resource-limited settings
por: Lee, Janice Soo Fern, et al.
Publicado: (2012)

Critical appraisal of ramelteon in the treatment of insomnia
por: Mets, Monique AJ, et al.
Publicado: (2010)

Critical appraisal of bevacizumab in the treatment of ovarian cancer
por: Yoshida, Hiroyuki, et al.
Publicado: (2015)

Critical appraisal of paroxetine for the treatment of vasomotor symptoms
por: Carroll, Dana G, et al.
Publicado: (2015)

A Multicenter Analysis of Elvitegravir Use During Pregnancy on HIV Viral Suppression and Perinatal Outcomes
por: Badell, Martina L, et al.
Publicado: (2019)

Novel elvitegravir nanoformulation for drug delivery across the blood-brain barrier to achieve HIV-1 suppression in the CNS macrophages
por: Gong, Yuqing, et al.
Publicado: (2020)

Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells
por: Midde, Narasimha M., et al.
Publicado: (2017)

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in the Treatment of HIV-Infected Patients: Experience with the First 100 Patients from Qatar
por: Al Soub, Hussam, et al.
Publicado: (2020)

Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Adults With HIV and M184V/I Mutation
por: Perez-Valero, Ignacio, et al.
Publicado: (2021)

Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study
por: Perez Stachowski, Javier, et al.
Publicado: (2022)

Three Main Mutational Pathways in HIV-2 Lead to High-Level Raltegravir and Elvitegravir Resistance: Implications for Emerging HIV-2 Treatment Regimens
por: Smith, Robert A., et al.
Publicado: (2012)

Critical appraisal of the role of fingolimod in the treatment of multiple sclerosis
por: Warnke, Clemens, et al.
Publicado: (2011)

Critical appraisal of trastuzumab in treatment of advanced stomach cancer
por: Meza-Junco, Judith, et al.
Publicado: (2011)

Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
por: Zoratto, Federica, et al.
Publicado: (2012)

Critical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria
por: Sadaba, Belen, et al.
Publicado: (2013)

Critical appraisal of ranibizumab in the treatment of diabetic macular edema
por: Stewart, Michael W
Publicado: (2013)

Fluorescent Protein Aided Insights on Plastids and their Extensions: A Critical Appraisal
por: Delfosse, Kathleen, et al.
Publicado: (2016)

Management of Patients with Treatment of Pheochromocytoma: A Critical Appraisal
por: Bihain, Florence, et al.
Publicado: (2022)

Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis
por: Valin, Nadia, et al.
Publicado: (2016)

A critical appraisal on Swarnaprashana in children
por: Jyothy, K.B., et al.
Publicado: (2014)

Critical appraisal of Doshavaha Srotas
por: Byadgi, Parameswarappa S.
Publicado: (2012)

Critical appraisal of published literature
por: Umesh, Goneppanavar, et al.
Publicado: (2016)

Curcumin enhances elvitegravir concentration and alleviates oxidative stress and inflammatory response
por: Godse, Sandip, et al.
Publicado: (2023)

Curcumin enhances elvitegravir concentration and alleviates oxidative stress and inflammatory response
por: Godse, Sandip, et al.
Publicado: (2023)

Critical appraisal of pemetrexed in the treatment of NSCLC and metastatic pulmonary nodules
por: Li, Xin, et al.
Publicado: (2014)

Critical appraisal of tocilizumab in the treatment of moderate to severe rheumatoid arthritis
por: Hushaw, Linda L, et al.
Publicado: (2010)

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
por: Cesareo, Roberto, et al.
Publicado: (2010)

Critical appraisal of nilotinib in frontline treatment of chronic myeloid leukemia
por: DeRemer, David L, et al.
Publicado: (2011)

Critical appraisal of the Spanner™ prostatic stent in the treatment of prostatic obstruction
por: McKenzie, Patrick, et al.
Publicado: (2011)

Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
por: Ansari, Jawaher, et al.
Publicado: (2013)

A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly
por: Gras-Miralles, Beatriz, et al.
Publicado: (2013)

Emerging treatments in Castleman disease – a critical appraisal of siltuximab
por: Koff, Jean L, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_avqkbkl84plfpheait1viubkkg